GNAS and COVID-19: The data suggests that, in addition to cortisol, growth factors, and other possible endocrinopathies, COVID-19 could potentially alter calcium homeostasis and the novel endocrine-related-proteins such as GNAS, which can potentially lead to further disruptions in calcium homeostasis and dysregulation of vascular permeability.